US2019117529A1PendingUtilityA1
Aqueous foaming cleansing compositions comprising n-acyl salts of polycarboxlic acids and plant microfibers
Est. expiryApr 7, 2036(~9.7 yrs left)· nominal 20-yr term from priority
A61K 8/97A61Q 19/10A61K 8/027A61K 8/442A61K 8/362A61K 8/046A61Q 5/02A61K 2800/596A61K 8/4946A61K 8/44A61K 8/731A61K 2800/48A61K 8/9789
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides liquid cleansing composition comprising having mild surfactant, specifically salts of N-acyl polycarboxylic acid where pH of composition is preferably 6.5 and below. By combining with particular defibrillated cell wall materials, the mild surfactants can be structured and also have surprisingly good foam stability.
Claims
exact text as granted — not AI-modified1 . A cleansing composition comprising:
1) 0.5 to 35% by wt. of total composition of a surfactant system which contains:
a) 0.5 to 25% by wt. of total composition anionic surfactant and
b) 0 to 20% by wt. of a co-surfactant selected from the group consisting of non-ionic surfactant, cationic surfactant, amphoteric surfactant and mixtures thereof; where an N-acyl salt of polycarboxylic acid is present at a level of 50% or more of all surfactant (both (a) and (b)); or is present at a level of 50% or more of anionic surfactant (a);
2) 0 to 30% by wt. of a hair or skin benefit agent; 3) 0.05 to 4.0 wt. % of a primary cell wall material comprising microfibers wherein:
a) the primary cell wall material is sourced from plant pararchymal tissue;
b) 80% or more (80% to 100% or 85% to 100%) of the microfibrils have a diameter of less than 50 nanometers (nm); and
4) balance of water wherein the primary cell wall material is defibrillated.
2 . A composition according to claim 1 having homogeneity parameter (CHP) of 0.030 and greater, according to the protocol as defined herein.
3 . (canceled)
4 . A composition according to claim 1 , wherein the cell wall material has a fiber homogeneity parameter (FHP) of 0.030 and greater, according to the protocol as defined herein.
5 . A composition according to claim 1 , wherein the cell wall has a fiber defibrillation parameter (FDP) of 0.10 Hz or greater, according to the protocol as defined herein.
6 . A composition according to claim 1 , wherein the salt of polycarboxylic acid is a salt of dicarboxylic acid.
7 . A composition according to claim 6 , wherein the salt of dicarboxylic acid is a salt of glutamate.
8 . A composition according to claim 7 , wherein pH of the composition is 3 to 6.5.Join the waitlist — get patent alerts
Track US2019117529A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.